• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性血小板增多症患者的非体外循环冠状动脉手术:同一患者出现两种危及生命的并发症。

Off-pump coronary artery surgery in a patient with essential thrombocythaemia: two life-threatening complications in the same patient.

作者信息

Kaya Kaan, Cavolli Raif, Telli Alpaslan, Tasoz Refik

机构信息

Ozel Ulus Hospital, Cardiovascular Surgery, Kazim Karabekir Bulvari, Aslanbey Caddesi, Atakent Sokak, No. 8, Iskitler, Ankara, Turkey.

出版信息

BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.01.2009.1503. Epub 2009 Aug 25.

DOI:10.1136/bcr.01.2009.1503
PMID:21866237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3027701/
Abstract

Essential thrombocythaemia (ET) is a rare chronic myeloproliferative disease characterised by persistent thrombocytosis. Cerebral, myocardial and peripheral thrombosis are frequently seen complications, but bleeding and venous thrombosis are more rare. Here, a case of essential thrombocythaemia complicated by cerebral and myocardial thrombosis is presented. The patient's platelet count was 680×10(9)/litre on admission. Electrocardiogram showed a slight ST elevation in leads V1 to V4. A coronary angiography was performed and it revealed a severe stenosis of the left anterior descending artery. The patient had a successful off-pump coronary artery bypass grafting surgery. After the operation the platelet count was 390×10(9)/litre. The patient received hydroxyurea and aspirin treatment preoperatively and continued postoperatively. ET is a rare myeloproliferative disease; its complications are also rare, but the occurrence of two life-threatening complications in the same patient is rarer still. Further investigations are needed to determine the risk stratification for patients with ET undergoing cardiac surgery.

摘要

原发性血小板增多症(ET)是一种罕见的慢性骨髓增殖性疾病,其特征为持续性血小板增多。脑、心肌和外周血栓形成是常见的并发症,但出血和静脉血栓形成则较为少见。本文报告一例原发性血小板增多症并发脑和心肌血栓形成的病例。患者入院时血小板计数为680×10⁹/升。心电图显示V1至V4导联ST段轻度抬高。进行了冠状动脉造影,结果显示左前降支严重狭窄。患者成功接受了非体外循环冠状动脉搭桥手术。术后血小板计数为390×10⁹/升。患者术前及术后均接受了羟基脲和阿司匹林治疗。原发性血小板增多症是一种罕见的骨髓增殖性疾病;其并发症也很罕见,但同一患者出现两种危及生命的并发症则更为罕见。需要进一步研究以确定接受心脏手术的原发性血小板增多症患者的风险分层。

相似文献

1
Off-pump coronary artery surgery in a patient with essential thrombocythaemia: two life-threatening complications in the same patient.原发性血小板增多症患者的非体外循环冠状动脉手术:同一患者出现两种危及生命的并发症。
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.01.2009.1503. Epub 2009 Aug 25.
2
Therapeutic dilemmas in the treatment of acute coronary syndrome as manifestation of essential thrombocythaemia.以原发性血小板增多症为表现的急性冠状动脉综合征治疗中的治疗困境
J Cardiol Cases. 2013 Oct 13;8(5):168-171. doi: 10.1016/j.jccase.2013.08.001. eCollection 2013 Nov.
3
Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.原发性血小板增多症高危患者的非体外循环下心肌血运重建术
Tex Heart Inst J. 2014 Oct 1;41(5):537-42. doi: 10.14503/THIJ-13-3508. eCollection 2014 Oct.
4
Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.体外循环与非体外循环冠状动脉搭桥手术患者早期血小板活化的比较。
J Thorac Cardiovasc Surg. 2007 Jul;134(1):132-8. doi: 10.1016/j.jtcvs.2007.01.055.
5
Percutaneous coronary intervention in a patient with heparin resistance due to essential thrombocythaemia: a case report.原发性血小板增多症导致肝素抵抗患者的经皮冠状动脉介入治疗:一例报告
Eur Heart J Case Rep. 2021 Mar 10;5(3):ytab087. doi: 10.1093/ehjcr/ytab087. eCollection 2021 Mar.
6
Platelet activity and aspirin efficacy after off-pump compared with on-pump coronary artery bypass surgery: results from the prospective randomized trial PRAGUE 11-Coronary Artery Bypass and REactivity of Thrombocytes (CABARET).非体外循环与体外循环冠状动脉搭桥术后血小板活性及阿司匹林疗效比较:前瞻性随机试验PRAGUE 11-冠状动脉搭桥与血小板反应性(CABARET)的结果
J Thorac Cardiovasc Surg. 2008 Oct;136(4):1054-60. doi: 10.1016/j.jtcvs.2008.03.052. Epub 2008 Jul 10.
7
Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgery.术前阿司匹林和氯吡格雷治疗对非体外循环冠状动脉搭桥手术患者围手术期失血及输血需求的影响。
J Thorac Cardiovasc Surg. 2007 Jul;134(1):59-64. doi: 10.1016/j.jtcvs.2007.03.013.
8
Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.原发性血小板增多症和真性红细胞增多症中血小板介导的微血管紊乱、主要血栓形成及出血并发症的病理生理学与治疗
Platelets. 2004 Mar;15(2):67-84. doi: 10.1080/09537100310001646969.
9
Evolution of Off-Pump Coronary Artery Bypass Grafting over 15 Years: A Single-Institution Experience of 14,030 Cases.非体外循环冠状动脉旁路移植术15年的发展历程:一家机构14030例病例的经验
Innovations (Phila). 2005 Winter;1(2):88-91. doi: 10.1097/01.imi.0000189937.33748.19.
10
Combined venous and arterial thrombosis revealing underlying myeloproliferative disorder in a young patient: a case report.年轻患者合并静脉和动脉血栓形成,提示潜在骨髓增殖性疾病:病例报告。
J Med Case Rep. 2021 Feb 16;15(1):76. doi: 10.1186/s13256-020-02593-5.

引用本文的文献

1
Off-pump myocardial revascularization in a high-risk patient with essential thrombocythemia.原发性血小板增多症高危患者的非体外循环下心肌血运重建术
Tex Heart Inst J. 2014 Oct 1;41(5):537-42. doi: 10.14503/THIJ-13-3508. eCollection 2014 Oct.

本文引用的文献

1
New advances in the pathogenesis and therapy of essential thrombocythemia.原发性血小板增多症的发病机制与治疗新进展
Hematology Am Soc Hematol Educ Program. 2008:76-82. doi: 10.1182/asheducation-2008.1.76.
2
Aortic valve replacement in a young patient with essential thrombocytosis.一名年轻原发性血小板增多症患者的主动脉瓣置换术
J Cardiothorac Surg. 2008 Jan 30;3:5. doi: 10.1186/1749-8090-3-5.
3
Comparison of early platelet activation in patients undergoing on-pump versus off-pump coronary artery bypass surgery.体外循环与非体外循环冠状动脉搭桥手术患者早期血小板活化的比较。
J Thorac Cardiovasc Surg. 2007 Jul;134(1):132-8. doi: 10.1016/j.jtcvs.2007.01.055.
4
Extending Jak2V617F and MplW515 mutation analysis to single hematopoietic colonies and B and T lymphocytes.将Jak2V617F和MplW515突变分析扩展至单个造血集落以及B淋巴细胞和T淋巴细胞。
Stem Cells. 2007 Sep;25(9):2358-62. doi: 10.1634/stemcells.2007-0175. Epub 2007 May 31.
5
Essential thrombocythemia in young individuals: frequency and risk factors for vascular events and evolution to myelofibrosis in 126 patients.年轻个体中的原发性血小板增多症:126例患者血管事件及向骨髓纤维化演变的发生率和危险因素
Leukemia. 2007 Jun;21(6):1218-23. doi: 10.1038/sj.leu.2404693. Epub 2007 Apr 12.
6
Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.世界卫生组织真性红细胞增多症、原发性血小板增多症和原发性骨髓纤维化诊断标准修订提案及理由:一个特设国际专家小组的建议
Blood. 2007 Aug 15;110(4):1092-7. doi: 10.1182/blood-2007-04-083501. Epub 2007 May 8.
7
Essential thrombocythemia beyond the first decade: life expectancy, long-term complication rates, and prognostic factors.十年后的原发性血小板增多症:预期寿命、长期并发症发生率及预后因素。
Mayo Clin Proc. 2006 Feb;81(2):159-66. doi: 10.4065/81.2.159.
8
Long-term outcome of 231 patients with essential thrombocythemia: prognostic factors for thrombosis, bleeding, myelofibrosis, and leukemia.231例原发性血小板增多症患者的长期预后:血栓形成、出血、骨髓纤维化和白血病的预后因素
Arch Intern Med. 2005;165(22):2651-8. doi: 10.1001/archinte.165.22.2651.
9
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study.基于JAK2 V617F突变状态的原发性血小板增多症亚型定义及其与真性红细胞增多症的关系:一项前瞻性研究。
Lancet. 2005 Dec 3;366(9501):1945-53. doi: 10.1016/S0140-6736(05)67785-9.
10
A gain-of-function mutation of JAK2 in myeloproliferative disorders.骨髓增殖性疾病中JAK2的功能获得性突变。
N Engl J Med. 2005 Apr 28;352(17):1779-90. doi: 10.1056/NEJMoa051113.